Cyclacel Pharmaceuticals Announces Exercise of Warrants for $2.1 Million Gross Proceeds

Yesterday

BERKELEY HEIGHTS, N.J., Nov. 13, 2024 ( GLOBE NEWSWIRE ) -- Cyclacel Pharmaceuticals, Inc. ( NASDAQ: CYCC, NASDAQ: CYCCP. "Cyclacel" or the "Company" ) , a biopharmaceutical company developing innovative cancer medicines, today announced that it has entered into a definitive agreement for the ...

Ticker	Sentiment	Impact
CYCC	Somewhat Bullish	17 %